September 11, 2023-September 13, 2023 View Now: 2023 Rare and Orphan Disease Conference presented by C-Path Patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists will leave this 2.5
September 28, 2023-September 29, 2023 Complex In Vitro Model: Qualification Framework Public Workshop Critical Path Institute’s Predictive Safety Testing Consortium hosted a public workshop on September 28-29, 2023 in Bethesda, Ma
June 15, 2023 US and UK policy responses to the challenges of repurposing approved drugs for new indications
June 20, 2023 C-Path’s Integrated Clinical Trial Database to Help Advance Research in Parkinson’s TUCSON, Ariz., June 20, 2023 — Critical Path Institute (C-Path), an independent nonprofit organization, today announced it is pr
June 28, 2023 C-Path’s TRxA Announces $750,000 in Research Awards to Accelerate its First Drug Development Projects TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda
July 6, 2023 Multistakeholder Collaborations Are Vital to Advancing Technologies in Parkinson’s TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Ro
July 6, 2023 Worldwide collaborative framework for optimizing new Parkinson’s treatment trials with patient centric outcome measures
August 10, 2023 View Now: Teaching Patients and Caregivers: The Role of Education in Research and Data Sharing Thursday, August 10, noon ET: This webinar will focus on the role of foundational education in research concepts, such as data lit
July 12, 2023 Sanford Health Rare Disease Data Registry Partners with C-Path’s RDCA-DAP, Cure Mito Foundation to Aggregate Rare Disease Data in Platform TUCSON, Ariz., July 12, 2023 — Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at